TCF7L2 and type 2 diabetes mellitus: Our prior discovery that the genomic region harboring the presumed T2D causal variant at the TCF7L2 locus, namely rs7903146, binds a protein complex that includes PARP-1 prompted us to functionally evaluate whether PARP-1 inhibition may have anti-diabetic effects.